Compliance software built for Med Spas
Medical spas sit at the intersection of FDA device rules, FTC endorsement rules, and state medical board supervision requirements - a regulatory triangle no other specialty deals with in the same way.
Why this specialty gets extra attention
Med spas are one of the more heavily enforced healthcare categories. The FDA treats injectables, lasers, and aesthetic devices as regulated medical products; the FTC reviews your marketing under the full Endorsement Guides; state medical boards treat your treatments as the practice of medicine. Any one of them can act on a single Instagram caption or homepage phrase. RegenCompliance is built to catch the specific patterns each one looks for - not as a generic marketing check, but as a med-spa-specific compliance review.
Active enforcement
What regulators are actually doing
FDA warning letters, FTC settlements, and state board actions that shape marketing rules for med spas.
FDA warning letters on off-label filler and toxin marketing
The FDA has issued letters to med spas marketing dermal fillers and neurotoxins for indications not included in the product labeling - 'non-surgical rhinoplasty' claims on fillers not FDA-approved for nasal use, or 'chin slimming' on neurotoxins approved for glabellar lines. These are disease-state adjacent claims that the FDA reads as unapproved use promotion.
FTC actions on before/after photo practices
The FTC Endorsement Guides require that before/after images fairly represent typical results. Med spa before/afters curated to show best-case outcomes - lighting, posing, Photoshop enhancement, or unrepresentative patient selection - have been cited as deceptive when paired with efficacy claims.
State medical board discipline on unsupervised treatment marketing
Most states require physician supervision for med-spa treatments. Marketing that implies aestheticians or nurse injectors operate independently - 'our licensed injectors,' 'book directly with your nurse' - has triggered state medical board investigations in California, Texas, Florida, and New York in particular.
FDA warning letters on laser energy marketing
'FDA-approved' and 'FDA-cleared' carry specific legal meanings. Using 'FDA-approved' on a laser device that is FDA-cleared but not approved, or marketing a cleared device for non-cleared indications, has generated letters across the aesthetic laser industry.
Specialty-specific phrase library
Risky phrases we catch (and lower-risk alternatives)
Each phrase below reflects patterns regulators have flagged. RegenCompliance catches them automatically on every scan, with a lower-risk alternative ready.
Higher-risk wording
“FDA-approved filler”
Why: Most fillers are FDA-cleared, not approved. These are legally distinct categories.
Lower-risk rewrite
“FDA-cleared for [specific labeled indication]”
Higher-risk wording
“Permanent results with one treatment”
Why: Efficacy and duration claims without substantiation; also conflicts with label data for most products.
Lower-risk rewrite
“Results typically last [range] for most patients; individual outcomes vary”
Higher-risk wording
“No side effects”
Why: Flat-out absence-of-harm claim is rarely substantiable and conflicts with prescribing information.
Lower-risk rewrite
“Most patients tolerate treatment well; potential side effects are discussed during consultation”
Higher-risk wording
“Non-surgical rhinoplasty”
Why: Implies the filler is approved for nasal reshaping; most are not.
Lower-risk rewrite
“Filler treatment to address concerns in the nasal area - limitations and candidacy discussed at consultation”
Higher-risk wording
“Reverses aging”
Why: Reversal / cure language on aesthetic concerns crosses into disease-claim territory.
Lower-risk rewrite
“Can improve the appearance of fine lines and restore volume for many patients”
Higher-risk wording
“Guaranteed results”
Why: Guarantee claims are almost never substantiable in aesthetic medicine.
Lower-risk rewrite
“Our patients typically report high satisfaction with their results”
Higher-risk wording
“Cures acne scarring”
Why: Disease-state cure language subject to FDA disease-claim rules.
Lower-risk rewrite
“Can significantly improve the appearance of acne scarring”
Higher-risk wording
“Book directly with our nurse injector”
Why: Implies independent practice in states requiring physician supervision of injectable treatments.
Lower-risk rewrite
“Consultations with our medical team, under the supervision of our medical director”
Higher-risk wording
“Revolutionary technology”
Why: Unsubstantiated superiority claim; also commonly flagged under FTC deceptive-advertising review.
Lower-risk rewrite
“Advanced technology proven in clinical use for [specific indication]”
Higher-risk wording
“Medical-grade at home results”
Why: Equivalence-to-medical-treatment claim without substantiation; misleads consumers about outcome comparability.
Lower-risk rewrite
“In-office treatments using professional-strength formulations not available over-the-counter”
Higher-risk wording
“Safer than surgery”
Why: Comparative safety claim requires head-to-head clinical evidence; rarely substantiable.
Lower-risk rewrite
“A non-surgical option for patients seeking [specific outcome]”
Higher-risk wording
“No downtime”
Why: Absolute claim; nearly every treatment has some downtime for some patients.
Lower-risk rewrite
“Minimal downtime - most patients return to normal activities within [timeframe]”
You’ve probably said this
Here’s a lower-risk way to say it.
These are phrases med spas have actually said (or considered saying). Each one triggers a specific FDA, FTC, or state board rule. Tap to see the rule and the rewrite.
On every scan
What we catch that generic tools miss
Instagram captions with 'before treatment / after treatment'
Short-form caption language is where FTC typical-experience disclosures are most often missed. Our scanner catches missing disclosures and suggests the exact insert text.
Injector bio pages claiming outcomes
Staff bio pages that claim clinical outcomes ('Nurse Smith has helped hundreds of patients achieve younger-looking skin') slip past most review because they are about the staff member - but they are still marketing claims subject to the same rules.
Pre-treatment consent language repurposed as marketing
Copy that works on a consent form - detailing treatment benefits to an already-committed patient - violates marketing rules when reused on a public service page.
Device manufacturer marketing reused verbatim
Many med spas copy device manufacturer marketing onto their own sites. Manufacturer marketing is written for B2B to clinics and often does not meet end-consumer rules. Our scanner catches this automatically.
Seasonal promotions layered with outcome claims
A 'Summer Skin' or 'New Year New You' promotion that layers a package deal on top of unsubstantiated outcome language is a common pattern in med spa marketing - and a common target for state medical board review.
Case study
A typical first scan on a med spa homepage
“Our revolutionary non-surgical rhinoplasty uses FDA-approved fillers to permanently reshape your nose with no side effects and no downtime. Book directly with our expert nurse injectors for guaranteed results - safer than surgery, proven to reverse signs of aging.”
“Our non-surgical approach uses FDA-cleared fillers to address concerns in the nasal area - candidacy and limitations discussed at consultation. Results typically last [range] for most patients; individual outcomes vary. Consultations with our medical team, under the supervision of our medical director. Most patients tolerate treatment well; potential side effects are reviewed during your consultation.”
Outcome
Score went from 18 to 87 across 9 flagged phrases. Full PDF audit report generated for the compliance file. No language removed - every phrase rewritten to lower the risk while still reading well.
Why RegenCompliance vs. generic tools
Med spa marketing lives in the overlap of FDA device-labeling rules, FTC endorsement rules, and state medical board supervision rules. A generic compliance tool might catch the obvious FDA disease claims; it will miss the supervision-implication language that state medical boards target and the typical-experience gaps that the FTC targets. RegenCompliance is built for the intersection, not just one dimension.
Who uses this
Built for every practice type in this specialty
Evaluating alternatives?
How RegenCompliance compares for med spas
Tools in the platform
What you actually get for med spas
Compliance Scanner
Med Spas-specific rule calibration. Flags disease claims, FDA misuse, and specialty-specific patterns.
Learn moreAI Compliant Rewriter
Turn flagged med spas claims into lower-risk alternatives that preserve your voice.
Learn moreAudit Trail + PDF Export
A clear record of your pre-publish review, ready to save to your files.
Learn moreFAQ
Med Spas-specific questions
Get started
Check your marketing.
Start scanning in about 30 seconds.
Unlimited scans. 3 team seats. Founding rate $297/mo locked for life. 30-day money-back guarantee - email support@regencompliance.ai within 30 days for a full refund.
See compliance built for weight loss clinics, regenerative medicine clinics, or dental practices. See all specialties
Further reading
Blog posts covering enforcement, claim categories, and tactical playbooks specifically relevant to med spas.
Med Spa Marketing: 12 Phrases That Put Your Clinic at Risk (and the Compliant Alternatives)
Med spas face a compliance environment most aesthetic marketers don't fully understand - three regulators overlap, cosmetic conditions blur into medical ones, and platform ad policies add a fourth layer. Here are 12 phrases to remove from your copy this week, with BeforeAfter rewrites.
Read articleBefore-and-After Photos: The FDA, FTC, HIPAA, and Platform Rules Nobody Talks About
Before-and-after photos are the most regulated visual in healthcare marketing - four overlapping regimes govern them simultaneously (FTC Endorsement Guides, FDA intent-of-use, HIPAA consent, platform ad policies). This is the complete compliant-photo protocol.
Read articleThe 7 Banned Words That Trigger FDA Warning Letters in Healthcare Marketing (2026 Update)
Seven specific words generate a disproportionate share of FDA warning letters and FTC actions in healthcare marketing. Here is the 2026 list - with the compliant alternative for every word and five adjacent phrases that drag you into the same violation.
Read article